Tacrolimus and corticosteroids versus tacrolimus, corticosteroids and basiliximab for control of acute rejection in de novo liver transplant recipients: A matched analysis.

被引：0
|
作者：
Sauer, IM
Langrehr, JM
Pascher, A
Bechstein, WO
Neuhaus, P
机构：
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
212
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Tacrolimus-Basiliximab versus cyclosporine-basiliximab in renal transplantation "De novo": Acute rejection and complications
    Garcia, DM
    Gago, JM
    Mendiluce, A
    Gordillo, R
    Bustamente, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1694 - 1696
  • [2] Pharmacokinetic interaction between tacrolimus and corticosteroids in liver transplant patients
    Provenzani, Alessio
    Di Stefano, Roberta
    Bavetta, Silvana
    Cammarata, Silvia
    Carollo, Anna
    Polidori, Piera
    Romano, Michael J.
    Sidoti, Maria Grazia
    Venuti, Francesca
    Zampardi, Valentina
    D'Alessandro, Natale
    Vizzini, Giovanni
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 48 - 48
  • [3] Everolimus with Reduced Tacrolimus Exposure Versus Standard Tacrolimus in Hepatitis C Virus Positive De Novo Liver Transplant Recipients.
    Saliba, F.
    De Simone, P.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Huang, M. A.
    Wang, Y.
    Sips, C.
    Lopez, P.
    Nevens, F.
    LIVER TRANSPLANTATION, 2012, 18 : S98 - S98
  • [4] Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids
    Asensio, M
    Margarit, C
    Chavez, R
    Ortega, J
    Charco, R
    Iglesias, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1970 - 1971
  • [5] RELATIONSHIP BETWEEN CORTICOSTEROIDS AND CONCENTRATION OF TACROLIMUS AND BIOCHEMICAL STATUS IN RENAL TRANSPLANT RECIPIENTS
    Velickovic-Radovanovic, R.
    Catic-Djordjevic, A.
    Paunovic, G.
    Cvetkovic, T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 151 - 151
  • [6] MELTDOSE® TECHNOLOGY VERSUS ONCE-DAILY PROLONGED RELEASE TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Baccarani, Umberto
    Pravisani, Riccardo
    Lorenzin, Dario
    Adani, Gian Luigi
    Cherchi, Vittorio
    Velkoski, Jaqueline
    Falzone, Bruno
    Baraldo, Massimo
    Risaliti, Andrea
    TRANSPLANT INTERNATIONAL, 2019, 32 : 330 - 330
  • [7] Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids
    Hricik, DE
    Anton, HAS
    Knauss, TC
    Rodriguez, V
    Seaman, D
    Siegel, C
    Valente, J
    Schulak, JA
    TRANSPLANTATION, 2002, 74 (02) : 189 - 193
  • [8] MeltDose technology versus once-daily prolonged release tacrolimus in de novo liver transplant recipients
    Baccarani, U.
    Pravisani, R.
    Lorenzin, D.
    Adani, G. L.
    Cherchi, V
    Velkosky, J.
    Falzone, B.
    Baraldo, M.
    Risaliti, A.
    TRANSPLANTATION, 2019, 103 (08) : 299 - 299
  • [9] Efficacy and safety of basiliximab with a Tacrolimus-based regimen in liver transplant recipients
    Marino, IR
    Doria, C
    Scott, VL
    Foglieni, CS
    Lauro, A
    Piazza, T
    Cintorino, D
    Gruttadauria, S
    TRANSPLANTATION, 2004, 78 (06) : 886 - 891
  • [10] Chronopharmacokinetics of tacrolimus in kidney transplant recipients: Occurrence of acute rejection
    Tada, H
    Satoh, S
    Iinuma, M
    Shimoda, N
    Murakami, M
    Hayase, Y
    Kato, T
    Suzuki, T
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (08): : 859 - 865
12345